|
 |
|
Home > In Vitro Diagnostics > Tumor Markers > Future Horizons and Growth Strategies in the US Tumor Marker Testing Market 2014: Supplier Shares and Country Forecasts
|
Future Horizons and Growth Strategies in the US Tumor Marker Testing Market 2014: Supplier Shares and Country Forecasts
|
 |
 |
 |
Highlights - Comprehensive 620-page analysis of the US tumor marker testing market.
- Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.
- Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others.
- Five-year test volume and sales forecasts over for 40 tumor marker performed in US hospitals, commercial laboratories and physician offices.
- Placements and installed base of automated and semi-automated analyzers used for tumor marker testing.
- Current instrumentation technologies and feature comparison of leading analyzers.
- Sales and market shares of leading suppliers.
- Emerging diagnostic technologies and their potential market applications.
- Product development opportunities.
- Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
- Business opportunities and strategic recommendations for suppliers.
Contains 620 pages and 103 tables
|
|
 |
|
|
|
|
|
|
|
Local PDF: $9700.00 Other Formats: Global PDF, DataPack
|
 |
|
|
|
|
|
|
|